Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Liposomal and Lipid-based Nanoparticle Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liposomal and Lipid-based Nanoparticle Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liposomal and Lipid-based Nanoparticle Drug Overall Market Size
2.1 Global Liposomal and Lipid-based Nanoparticle Drug Market Size: 2021 VS 2028
2.2 Global Liposomal and Lipid-based Nanoparticle Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Liposomal and Lipid-based Nanoparticle Drug Players in Global Market
3.2 Top Global Liposomal and Lipid-based Nanoparticle Drug Companies Ranked by Revenue
3.3 Global Liposomal and Lipid-based Nanoparticle Drug Revenue by Companies
3.4 Top 3 and Top 5 Liposomal and Lipid-based Nanoparticle Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Liposomal and Lipid-based Nanoparticle Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Liposomal and Lipid-based Nanoparticle Drug Players in Global Market
3.6.1 List of Global Tier 1 Liposomal and Lipid-based Nanoparticle Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Liposomal and Lipid-based Nanoparticle Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Liposomal and Lipid-based Nanoparticle Drug Market Size Markets, 2021 & 2028
4.1.2 Liposomes Drugs
4.1.3 Lipid Nanoparticle Drugs
4.2 By Type - Global Liposomal and Lipid-based Nanoparticle Drug Revenue & Forecasts
4.2.1 By Type - Global Liposomal and Lipid-based Nanoparticle Drug Revenue, 2017-2022
4.2.2 By Type - Global Liposomal and Lipid-based Nanoparticle Drug Revenue, 2023-2028
4.2.3 By Type - Global Liposomal and Lipid-based Nanoparticle Drug Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Liposomal and Lipid-based Nanoparticle Drug Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Liposomal and Lipid-based Nanoparticle Drug Revenue & Forecasts
5.2.1 By Application - Global Liposomal and Lipid-based Nanoparticle Drug Revenue, 2017-2022
5.2.2 By Application - Global Liposomal and Lipid-based Nanoparticle Drug Revenue, 2023-2028
5.2.3 By Application - Global Liposomal and Lipid-based Nanoparticle Drug Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Liposomal and Lipid-based Nanoparticle Drug Market Size, 2021 & 2028
6.2 By Region - Global Liposomal and Lipid-based Nanoparticle Drug Revenue & Forecasts
6.2.1 By Region - Global Liposomal and Lipid-based Nanoparticle Drug Revenue, 2017-2022
6.2.2 By Region - Global Liposomal and Lipid-based Nanoparticle Drug Revenue, 2023-2028
6.2.3 By Region - Global Liposomal and Lipid-based Nanoparticle Drug Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Liposomal and Lipid-based Nanoparticle Drug Revenue, 2017-2028
6.3.2 US Liposomal and Lipid-based Nanoparticle Drug Market Size, 2017-2028
6.3.3 Canada Liposomal and Lipid-based Nanoparticle Drug Market Size, 2017-2028
6.3.4 Mexico Liposomal and Lipid-based Nanoparticle Drug Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Liposomal and Lipid-based Nanoparticle Drug Revenue, 2017-2028
6.4.2 Germany Liposomal and Lipid-based Nanoparticle Drug Market Size, 2017-2028
6.4.3 France Liposomal and Lipid-based Nanoparticle Drug Market Size, 2017-2028
6.4.4 U.K. Liposomal and Lipid-based Nanoparticle Drug Market Size, 2017-2028
6.4.5 Italy Liposomal and Lipid-based Nanoparticle Drug Market Size, 2017-2028
6.4.6 Russia Liposomal and Lipid-based Nanoparticle Drug Market Size, 2017-2028
6.4.7 Nordic Countries Liposomal and Lipid-based Nanoparticle Drug Market Size, 2017-2028
6.4.8 Benelux Liposomal and Lipid-based Nanoparticle Drug Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Liposomal and Lipid-based Nanoparticle Drug Revenue, 2017-2028
6.5.2 China Liposomal and Lipid-based Nanoparticle Drug Market Size, 2017-2028
6.5.3 Japan Liposomal and Lipid-based Nanoparticle Drug Market Size, 2017-2028
6.5.4 South Korea Liposomal and Lipid-based Nanoparticle Drug Market Size, 2017-2028
6.5.5 Southeast Asia Liposomal and Lipid-based Nanoparticle Drug Market Size, 2017-2028
6.5.6 India Liposomal and Lipid-based Nanoparticle Drug Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Liposomal and Lipid-based Nanoparticle Drug Revenue, 2017-2028
6.6.2 Brazil Liposomal and Lipid-based Nanoparticle Drug Market Size, 2017-2028
6.6.3 Argentina Liposomal and Lipid-based Nanoparticle Drug Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Liposomal and Lipid-based Nanoparticle Drug Revenue, 2017-2028
6.7.2 Turkey Liposomal and Lipid-based Nanoparticle Drug Market Size, 2017-2028
6.7.3 Israel Liposomal and Lipid-based Nanoparticle Drug Market Size, 2017-2028
6.7.4 Saudi Arabia Liposomal and Lipid-based Nanoparticle Drug Market Size, 2017-2028
6.7.5 UAE Liposomal and Lipid-based Nanoparticle Drug Market Size, 2017-2028
7 Players Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Liposomal and Lipid-based Nanoparticle Drug Major Product Offerings
7.1.4 Johnson & Johnson Liposomal and Lipid-based Nanoparticle Drug Revenue in Global Market (2017-2022)
7.1.5 Johnson & Johnson Key News
7.2 Sun Pharmaceutical
7.2.1 Sun Pharmaceutical Corporate Summary
7.2.2 Sun Pharmaceutical Business Overview
7.2.3 Sun Pharmaceutical Liposomal and Lipid-based Nanoparticle Drug Major Product Offerings
7.2.4 Sun Pharmaceutical Liposomal and Lipid-based Nanoparticle Drug Revenue in Global Market (2017-2022)
7.2.5 Sun Pharmaceutical Key News
7.3 CSPC
7.3.1 CSPC Corporate Summary
7.3.2 CSPC Business Overview
7.3.3 CSPC Liposomal and Lipid-based Nanoparticle Drug Major Product Offerings
7.3.4 CSPC Liposomal and Lipid-based Nanoparticle Drug Revenue in Global Market (2017-2022)
7.3.5 CSPC Key News
7.4 Kinyond
7.4.1 Kinyond Corporate Summary
7.4.2 Kinyond Business Overview
7.4.3 Kinyond Liposomal and Lipid-based Nanoparticle Drug Major Product Offerings
7.4.4 Kinyond Liposomal and Lipid-based Nanoparticle Drug Revenue in Global Market (2017-2022)
7.4.5 Kinyond Key News
7.5 Teva
7.5.1 Teva Corporate Summary
7.5.2 Teva Business Overview
7.5.3 Teva Liposomal and Lipid-based Nanoparticle Drug Major Product Offerings
7.5.4 Teva Liposomal and Lipid-based Nanoparticle Drug Revenue in Global Market (2017-2022)
7.5.5 Teva Key News
7.6 Fudan-Zhangjiang
7.6.1 Fudan-Zhangjiang Corporate Summary
7.6.2 Fudan-Zhangjiang Business Overview
7.6.3 Fudan-Zhangjiang Liposomal and Lipid-based Nanoparticle Drug Major Product Offerings
7.6.4 Fudan-Zhangjiang Liposomal and Lipid-based Nanoparticle Drug Revenue in Global Market (2017-2022)
7.6.5 Fudan-Zhangjiang Key News
7.7 Zydus Cadila
7.7.1 Zydus Cadila Corporate Summary
7.7.2 Zydus Cadila Business Overview
7.7.3 Zydus Cadila Liposomal and Lipid-based Nanoparticle Drug Major Product Offerings
7.7.4 Zydus Cadila Liposomal and Lipid-based Nanoparticle Drug Revenue in Global Market (2017-2022)
7.7.5 Zydus Cadila Key News
7.8 TTY Biopharma
7.8.1 TTY Biopharma Corporate Summary
7.8.2 TTY Biopharma Business Overview
7.8.3 TTY Biopharma Liposomal and Lipid-based Nanoparticle Drug Major Product Offerings
7.8.4 TTY Biopharma Liposomal and Lipid-based Nanoparticle Drug Revenue in Global Market (2017-2022)
7.8.5 TTY Biopharma Key News
7.9 Pacira
7.9.1 Pacira Corporate Summary
7.9.2 Pacira Business Overview
7.9.3 Pacira Liposomal and Lipid-based Nanoparticle Drug Major Product Offerings
7.9.4 Pacira Liposomal and Lipid-based Nanoparticle Drug Revenue in Global Market (2017-2022)
7.9.5 Pacira Key News
7.10 Luye Pharma
7.10.1 Luye Pharma Corporate Summary
7.10.2 Luye Pharma Business Overview
7.10.3 Luye Pharma Liposomal and Lipid-based Nanoparticle Drug Major Product Offerings
7.10.4 Luye Pharma Liposomal and Lipid-based Nanoparticle Drug Revenue in Global Market (2017-2022)
7.10.5 Luye Pharma Key News
7.11 Leadiant Biosciences
7.11.1 Leadiant Biosciences Corporate Summary
7.11.2 Leadiant Biosciences Business Overview
7.11.3 Leadiant Biosciences Liposomal and Lipid-based Nanoparticle Drug Major Product Offerings
7.11.4 Leadiant Biosciences Liposomal and Lipid-based Nanoparticle Drug Revenue in Global Market (2017-2022)
7.11.5 Leadiant Biosciences Key News
7.12 Ipsen
7.12.1 Ipsen Corporate Summary
7.12.2 Ipsen Business Overview
7.12.3 Ipsen Liposomal and Lipid-based Nanoparticle Drug Major Product Offerings
7.12.4 Ipsen Liposomal and Lipid-based Nanoparticle Drug Revenue in Global Market (2017-2022)
7.12.5 Ipsen Key News
7.13 Sayre Therapeutics
7.13.1 Sayre Therapeutics Corporate Summary
7.13.2 Sayre Therapeutics Business Overview
7.13.3 Sayre Therapeutics Liposomal and Lipid-based Nanoparticle Drug Major Product Offerings
7.13.4 Sayre Therapeutics Liposomal and Lipid-based Nanoparticle Drug Revenue in Global Market (2017-2022)
7.13.5 Sayre Therapeutics Key News
7.14 Jazz
7.14.1 Jazz Corporate Summary
7.14.2 Jazz Business Overview
7.14.3 Jazz Liposomal and Lipid-based Nanoparticle Drug Major Product Offerings
7.14.4 Jazz Liposomal and Lipid-based Nanoparticle Drug Revenue in Global Market (2017-2022)
7.14.5 Jazz Key News
7.15 Alnylam
7.15.1 Alnylam Corporate Summary
7.15.2 Alnylam Business Overview
7.15.3 Alnylam Liposomal and Lipid-based Nanoparticle Drug Major Product Offerings
7.15.4 Alnylam Liposomal and Lipid-based Nanoparticle Drug Revenue in Global Market (2017-2022)
7.15.5 Alnylam Key News
7.16 Bausch Health
7.16.1 Bausch Health Corporate Summary
7.16.2 Bausch Health Business Overview
7.16.3 Bausch Health Liposomal and Lipid-based Nanoparticle Drug Major Product Offerings
7.16.4 Bausch Health Liposomal and Lipid-based Nanoparticle Drug Revenue in Global Market (2017-2022)
7.16.5 Bausch Health Key News
7.17 Acrotech Biopharma
7.17.1 Acrotech Biopharma Corporate Summary
7.17.2 Acrotech Biopharma Business Overview
7.17.3 Acrotech Biopharma Liposomal and Lipid-based Nanoparticle Drug Major Product Offerings
7.17.4 Acrotech Biopharma Liposomal and Lipid-based Nanoparticle Drug Revenue in Global Market (2017-2022)
7.17.5 Acrotech Biopharma Key News
7.18 Takeda
7.18.1 Takeda Corporate Summary
7.18.2 Takeda Business Overview
7.18.3 Takeda Liposomal and Lipid-based Nanoparticle Drug Major Product Offerings
7.18.4 Takeda Liposomal and Lipid-based Nanoparticle Drug Revenue in Global Market (2017-2022)
7.18.5 Takeda Key News
7.19 Chiesi Farmaceutici
7.19.1 Chiesi Farmaceutici Corporate Summary
7.19.2 Chiesi Farmaceutici Business Overview
7.19.3 Chiesi Farmaceutici Liposomal and Lipid-based Nanoparticle Drug Major Product Offerings
7.19.4 Chiesi Farmaceutici Liposomal and Lipid-based Nanoparticle Drug Revenue in Global Market (2017-2022)
7.19.5 Chiesi Farmaceutici Key News
7.20 Gilead Sciences
7.20.1 Gilead Sciences Corporate Summary
7.20.2 Gilead Sciences Business Overview
7.20.3 Gilead Sciences Liposomal and Lipid-based Nanoparticle Drug Major Product Offerings
7.20.4 Gilead Sciences Liposomal and Lipid-based Nanoparticle Drug Revenue in Global Market (2017-2022)
7.20.5 Gilead Sciences Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer